Seth Gibbs Selected Research

Non-alcoholic Fatty Liver Disease

12/2019

Preclinical toxicity evaluation of JD5037, a peripherally restricted CB1 receptor inverse agonist, in rats and dogs for treatment of nonalcoholic steatohepatitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Seth Gibbs Research Topics

Disease

2	Seizures (Absence Seizure) 11/2020 - 09/2013
2	Neoplasms (Cancer) 03/2007 - 01/2007
1	Melioidosis 10/2023
1	Edema (Dropsy) 11/2021
1	Hemorrhage 11/2021
1	Body Weight (Weight, Body) 01/2020
1	Non-alcoholic Fatty Liver Disease 12/2019
1	Dyslipidemias (Dyslipidemia) 12/2019
1	Abdominal Obesity 12/2019
1	Cardiotoxicity 11/2018
1	Hypoxia (Hypoxemia) 03/2007
1	Colorectal Neoplasms (Colorectal Cancer) 02/2007
1	Leukemia 01/2007

Drug/Important Bio-Agent (IBA)

1	Biological Warfare AgentsIBA 10/2023
1	Ceftazidime (Fortum)FDA LinkGeneric 10/2023
1	FibrinIBA 11/2021
1	cyclocreatineIBA 11/2020
1	N-butylbenzenesulfonamide (NBBS)IBA 01/2020
1	JD5037IBA 12/2019
1	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 12/2019
1	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2018
1	beta-thujone (thujone)IBA 09/2013
1	PhloretinIBA 03/2007
1	Glucose (Dextrose)FDA LinkGeneric 03/2007
1	EnzymesIBA 03/2007
1	DNA (Deoxyribonucleic Acid)IBA 03/2007
1	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 03/2007
1	Daunorubicin (Cerubidine)FDA LinkGeneric 03/2007
1	Monoclonal AntibodiesIBA 02/2007
1	Proteins (Proteins, Gene)FDA Link 01/2007

Therapy/Procedure

1	Therapeutics 01/2007